1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nuclear Medicine/Radiopharmaceutic Revenue
1.4 Market Analysis by Type
1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Tc-99
1.4.3 I-123/131
1.4.4 In-111
1.4.5 Xe-133
1.4.6 Th-201
1.4.7 Ga-67
1.4.8 Other
1.5 Market by Application
1.5.1 Global Nuclear Medicine/Radiopharmaceutic Market Share by Application: 2021-2026
1.5.2 Diagnostic
1.5.3 Therapeutic
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Nuclear Medicine/Radiopharmaceutic Market
1.8.1 Global Nuclear Medicine/Radiopharmaceutic Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Nuclear Medicine/Radiopharmaceutic Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Nuclear Medicine/Radiopharmaceutic Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Nuclear Medicine/Radiopharmaceutic Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Region (2015-2020)
3.2 Global Nuclear Medicine/Radiopharmaceutic Sales Revenue Market Share by Region (2015-2020)
3.3 North America Nuclear Medicine/Radiopharmaceutic Sales Volume
3.3.1 North America Nuclear Medicine/Radiopharmaceutic Sales Volume Growth Rate (2015-2020)
3.3.2 North America Nuclear Medicine/Radiopharmaceutic Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Nuclear Medicine/Radiopharmaceutic Sales Volume
3.4.1 East Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Nuclear Medicine/Radiopharmaceutic Sales Volume (2015-2020)
3.5.1 Europe Nuclear Medicine/Radiopharmaceutic Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Nuclear Medicine/Radiopharmaceutic Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Nuclear Medicine/Radiopharmaceutic Sales Volume (2015-2020)
3.6.1 South Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume (2015-2020)
3.7.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Nuclear Medicine/Radiopharmaceutic Sales Volume (2015-2020)
3.8.1 Middle East Nuclear Medicine/Radiopharmaceutic Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Nuclear Medicine/Radiopharmaceutic Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Nuclear Medicine/Radiopharmaceutic Sales Volume (2015-2020)
3.9.1 Africa Nuclear Medicine/Radiopharmaceutic Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Nuclear Medicine/Radiopharmaceutic Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Nuclear Medicine/Radiopharmaceutic Sales Volume (2015-2020)
3.10.1 Oceania Nuclear Medicine/Radiopharmaceutic Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Nuclear Medicine/Radiopharmaceutic Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Nuclear Medicine/Radiopharmaceutic Sales Volume (2015-2020)
3.11.1 South America Nuclear Medicine/Radiopharmaceutic Sales Volume Growth Rate (2015-2020)
3.11.2 South America Nuclear Medicine/Radiopharmaceutic Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Nuclear Medicine/Radiopharmaceutic Sales Volume (2015-2020)
3.12.1 Rest of the World Nuclear Medicine/Radiopharmaceutic Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Nuclear Medicine/Radiopharmaceutic Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Nuclear Medicine/Radiopharmaceutic Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Nuclear Medicine/Radiopharmaceutic Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Nuclear Medicine/Radiopharmaceutic Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Nuclear Medicine/Radiopharmaceutic Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Nuclear Medicine/Radiopharmaceutic Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Nuclear Medicine/Radiopharmaceutic Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Nuclear Medicine/Radiopharmaceutic Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Nuclear Medicine/Radiopharmaceutic Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Nuclear Medicine/Radiopharmaceutic Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2015-2020)
14.2 Global Nuclear Medicine/Radiopharmaceutic Sales Revenue Market Share by Type (2015-2020)
14.3 Global Nuclear Medicine/Radiopharmaceutic Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Nuclear Medicine/Radiopharmaceutic Consumption Volume by Application (2015-2020)
15.2 Global Nuclear Medicine/Radiopharmaceutic Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Nuclear Medicine/Radiopharmaceutic Business
16.1 GE Healthcare
16.1.1 GE Healthcare Company Profile
16.1.2 GE Healthcare Nuclear Medicine/Radiopharmaceutic Product Specification
16.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Eli Lilly
16.2.1 Eli Lilly Company Profile
16.2.2 Eli Lilly Nuclear Medicine/Radiopharmaceutic Product Specification
16.2.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Lantheus Medical Imaging
16.3.1 Lantheus Medical Imaging Company Profile
16.3.2 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product Specification
16.3.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Bracco Imaging
16.4.1 Bracco Imaging Company Profile
16.4.2 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product Specification
16.4.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Nordion
16.5.1 Nordion Company Profile
16.5.2 Nordion Nuclear Medicine/Radiopharmaceutic Product Specification
16.5.3 Nordion Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Mallinckrodt
16.6.1 Mallinckrodt Company Profile
16.6.2 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product Specification
16.6.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 China Isotope & Radiation
16.7.1 China Isotope & Radiation Company Profile
16.7.2 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product Specification
16.7.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Jubilant Pharma
16.8.1 Jubilant Pharma Company Profile
16.8.2 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product Specification
16.8.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Bayer
16.9.1 Bayer Company Profile
16.9.2 Bayer Nuclear Medicine/Radiopharmaceutic Product Specification
16.9.3 Bayer Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 SIEMENS
16.10.1 SIEMENS Company Profile
16.10.2 SIEMENS Nuclear Medicine/Radiopharmaceutic Product Specification
16.10.3 SIEMENS Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Yantai Dongcheng Biochemicals
16.11.1 Yantai Dongcheng Biochemicals Company Profile
16.11.2 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product Specification
16.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Nuclear Medicine/Radiopharmaceutic Manufacturing Cost Analysis
17.1 Nuclear Medicine/Radiopharmaceutic Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
17.4 Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Nuclear Medicine/Radiopharmaceutic Distributors List
18.3 Nuclear Medicine/Radiopharmaceutic Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Nuclear Medicine/Radiopharmaceutic (2021-2026)
20.2 Global Forecasted Revenue of Nuclear Medicine/Radiopharmaceutic (2021-2026)
20.3 Global Forecasted Price of Nuclear Medicine/Radiopharmaceutic (2015-2026)
20.4 Global Forecasted Production of Nuclear Medicine/Radiopharmaceutic by Region (2021-2026)
20.4.1 North America Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026)
20.4.3 Europe Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026)
20.4.7 Africa Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026)
20.4.9 South America Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Nuclear Medicine/Radiopharmaceutic Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country
21.2 East Asia Market Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country
21.3 Europe Market Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Countriy
21.4 South Asia Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country
21.5 Southeast Asia Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country
21.6 Middle East Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country
21.7 Africa Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country
21.8 Oceania Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country
21.9 South America Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country
21.10 Rest of the world Forecasted Consumption of Nuclear Medicine/Radiopharmaceutic by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer